Olmesartan/Amlodipin/Hct Al

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin/Hct Al, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when monotherapy is insufficient.

GNH USA supplies Olmesartan/Amlodipin/Hct Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/Amlodipin/Hct Al is used for hypertension management, targeting multiple pathways that regulate blood pressure. - Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with fluid retention: combines vasodilation with diuretic action to improve blood‑pressure control. - Hypertension resistant to monotherapy: provides additive effect when single agents are inadequate.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache - Peripheral edema - Dizziness - Flushing - Fatigue - Cough

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Electrolyte disturbances (e.g., hyponatremia, hyperkalemia) - Angio‑angelf   - Liver enzyme elevation. - Panpan  

When prescribing ​   g   t   d \